Venous thromboembolism in patients with diabetes mellitus

American Journal of Medicine

Volumn 125, Issue 7, 2012, Pages 709-716

  Piazza, Gregory ^a   Goldhaber, Samuel Z ^a   Kroll, Aimee ^b   Goldberg, Robert J ^b   Emery, Catherine ^b   Spencer, Frederick A ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Deep vein thrombosis; Diabetes mellitus; Prophylaxis; Pulmonary embolism; Treatment; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84862657225     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.12.004     Document Type: Article

References (27)

1. Piazza G, Goldhaber SZ. Venous thromboembolism and atherothrombosis. Circulation. 2010;121:2146-2150.
2. Centers for Disease Control and Prevention. Crude and age-adjusted incidence of diagnosed diabetes per 1,000 population aged 18-79 years, United States, 1980-2009 (2011). Available at: http://www.cdc.gov/diabetes/statistics/ incidence/fig2.htm. Accessed September 20, 2011.
3. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121:1896-1903.
4. Heit JA, Leibson CL, Ashrani AA, et al. Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol. 2009;29: 1399-1405.
5. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162: 1182-1189.
6. Stein PD, Goldman J, Matta F, Yaekoub AY. Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci. 2009;337:259-264.
7. Petrauskiene V, Falk M, Waernbaum I, et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48:1017-1021.
8. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008; 117:93-102.
9. Tripodi A, Branchi A, Chantarangkul V, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31:165-172.
10. Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006; 21:722-727.
11. Spencer FA, Emery C, Lessard D, Goldberg RJ. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med. 2007; 120:678-684.
12. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585-593.
13. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694.
14. Piazza G, Seddighzadeh A, Goldhaber SZ. Heart failure in patients with deep vein thrombosis. Am J Cardiol. 2008;101:1056-1059.
15. Piazza G, Goldhaber SZ, Lessard DM, et al. Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med. 2011;124:252-259.
16. Shetty R, Seddighzadeh A, Piazza G, Goldhaber SZ. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis. 2008;26:35-40.
17. Monreal M, Munoz-Torrero JF, Naraine VS, et al. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. Am J Med. 2006;119:851-858.
18. Piazza G, Goldhaber SZ, Lessard DM, et al. Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost. 2011; 106(6):1095-1102.
19. Daneschvar HL, Seddighzadeh A, Piazza G, Goldhaber SZ. Deep vein thrombosis in patients with chronic kidney disease. Thromb Haemost. 2008;99:1035-1039.
20. Tsimerman G, Roguin A, Bachar A, et al. Involvement of microparticles in diabetic vascular complications. Thromb Haemost. 2011;106: 310-321.
21. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009;119:1873-1882.
22. Alberts MJ, Bhatt DL, Smith SC Jr, et al. Risk factors and outcomes for patients with vascular disease and serious bleeding events. Heart. 2011;97:1507-1512.
23. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936-945.
24. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119:145-155.
25. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-394.
26. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007;5: 1610-1616.
27. Alpert JS. Are data from clinical registries of any value? Eur Heart J. 2000;21:1399-1401.